|Articles|March 1, 2017
Eppendorf
Advertisement
We Know Bioprocessing
By exploiting the strong synergies in bioreactor technology and polymer manufacturing, Eppendorf has emerged as a global player in the bioprocess marketplace. With a comprehensive offering of single-use and traditional products for the growth of mammalian and microbial cells, and working volumes of 60 mL–2400 L, the Eppendorf bioprocess portfolio can satisfy the demands of process development through production.
INTERPHEX Booth #3639
Newsletter
Stay at the forefront of biopharmaceutical innovation—subscribe to BioPharm International for expert insights on drug development, manufacturing, compliance, and more.
Advertisement
Advertisement
Advertisement
Trending on BioPharm International
1
Novel Delivery Approaches of Biopharmaceuticals 2025
2
FAQ: What You Need to Know about the Current Antibody Pipeline
3
Samsung Biologics Bolsters US Manufacturing Network with GSK Facility Buy
4
GSK and CAMP4 Partner to Advance RNA-Targeting Therapeutics
5
